179 related articles for article (PubMed ID: 24187541)
1. Effect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats.
Menzies RI; Unwin RJ; Dash RK; Beard DA; Cowley AW; Carlson BE; Mullins JJ; Bailey MA
Front Physiol; 2013; 4():305. PubMed ID: 24187541
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats.
Nespoux J; Monaghan MT; Jones NK; Stewart K; Denby L; Czopek A; Mullins JJ; Menzies RI; Baker AH; Bailey MA
Sci Rep; 2024 Apr; 14(1):9573. PubMed ID: 38670993
[TBL] [Abstract][Full Text] [Related]
3. The Role of P2X7 Purinergic Receptors in the Renal Inflammation Associated with Angiotensin II-induced Hypertension.
Bautista-Pérez R; Pérez-Méndez O; Cano-Martínez A; Pacheco U; Santamaría J; Rodríguez-Iturbe FRB; Navar LG; Franco M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516946
[TBL] [Abstract][Full Text] [Related]
4. Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.
Pereira JMS; Barreira AL; Gomes CR; Ornellas FM; Ornellas DS; Miranda LC; Cardoso LR; Coutinho-Silva R; Schanaider A; Morales MM; Leite M; Takiya CM
BMC Nephrol; 2020 May; 21(1):206. PubMed ID: 32471386
[TBL] [Abstract][Full Text] [Related]
5. P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.
Ji X; Naito Y; Hirokawa G; Weng H; Hiura Y; Takahashi R; Iwai N
Hypertens Res; 2012 Feb; 35(2):173-9. PubMed ID: 21918525
[TBL] [Abstract][Full Text] [Related]
6. The relationship between P2X4 and P2X7: a physiologically important interaction?
Craigie E; Birch RE; Unwin RJ; Wildman SS
Front Physiol; 2013; 4():216. PubMed ID: 23966951
[TBL] [Abstract][Full Text] [Related]
7. Physiopathological implications of P2X
Franco M; Bautista-Pérez R; Cano-Martínez A; Pacheco U; Santamaría J; Del Valle Mondragón L; Pérez-Méndez O; Navar LG
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F9-F19. PubMed ID: 28404593
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.
Peng W; Cotrina ML; Han X; Yu H; Bekar L; Blum L; Takano T; Tian GF; Goldman SA; Nedergaard M
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12489-93. PubMed ID: 19666625
[TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats.
Chen S; Ma Q; Krafft PR; Chen Y; Tang J; Zhang J; Zhang JH
Crit Care Med; 2013 Dec; 41(12):e466-74. PubMed ID: 23963136
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitizing Effect of P2X7 Receptor Antagonist on Melanoma in Vitro and in Vivo.
Tanamachi K; Nishino K; Mori N; Suzuki T; Tanuma SI; Abe R; Tsukimoto M
Biol Pharm Bull; 2017 Jun; 40(6):878-887. PubMed ID: 28344198
[TBL] [Abstract][Full Text] [Related]
11. A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.
Marcillo A; Frydel B; Bramlett HM; Dietrich WD
Exp Neurol; 2012 Feb; 233(2):687-92. PubMed ID: 22078760
[TBL] [Abstract][Full Text] [Related]
12. The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes.
Lu W; Albalawi F; Beckel JM; Lim JC; Laties AM; Mitchell CH
J Neurochem; 2017 May; 141(3):436-448. PubMed ID: 28244110
[TBL] [Abstract][Full Text] [Related]
13. Renal vasculature reactivity to agonist of P2X7 receptor is increased in streptozotocin-induced diabetes.
Kreft E; Kowalski R; Jankowski M; Szczepańska-Konkel M
Pharmacol Rep; 2016 Feb; 68(1):71-4. PubMed ID: 26721355
[TBL] [Abstract][Full Text] [Related]
14. Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
Mackenzie HS; Ziai F; Nagano H; Azuma H; Troy JL; Rennke HG; Tilney NL; Brenner BM
J Hypertens Suppl; 1997 Dec; 15(6):S21-5. PubMed ID: 9493123
[TBL] [Abstract][Full Text] [Related]
15. Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model.
Ribeiro DE; Casarotto PC; Staquini L; Pinto E Silva MA; Biojone C; Wegener G; Joca S
PeerJ; 2019; 7():e7834. PubMed ID: 31656696
[TBL] [Abstract][Full Text] [Related]
16. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
[TBL] [Abstract][Full Text] [Related]
17. P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or neuroprotection after stroke in adult mice.
Kang SS; Keasey MP; Hagg T
Transl Stroke Res; 2013 Oct; 4(5):533-45. PubMed ID: 24312160
[TBL] [Abstract][Full Text] [Related]
18. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
[TBL] [Abstract][Full Text] [Related]
19. P2X7 receptor antagonist BBG inhibits endoplasmic reticulum stress and pyroptosis to alleviate postherpetic neuralgia.
Zhu Y; Zhang S; Wu Y; Wang J
Mol Cell Biochem; 2021 Sep; 476(9):3461-3468. PubMed ID: 33982210
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats.
Wang YC; Cui Y; Cui JZ; Sun LQ; Cui CM; Zhang HA; Zhu HX; Li R; Tian YX; Gao JL
Mol Med Rep; 2015 Aug; 12(2):2149-54. PubMed ID: 25873133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]